Mutation of the <scp>TP53</scp> gene in acute lymphoblastic leukemia does not affect survival outcomes after haploidentical hematopoietic stem cell transplantation-Reference-Cited by-同舟云学术

Mutation of the TP53 gene in acute lymphoblastic leukemia does not affect survival outcomes after haploidentical hematopoietic stem cell transplantation

Published:2022-10-26 Issue:5 Volume:152 Page:977-985
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Intl Journal of Cancer

Author:

Zhou Cuiyan¹²,Zheng Fengmei¹²,Xu Lanping¹²,Zhang Xiaohui¹²,Chang Yingjun¹²,Mo Xiaodong¹²^ORCID,Sun Yuqian¹²,Huang Xiaojun¹²³,Wang Yu¹²^ORCID

Affiliation:

1. Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease Beijing China

2. Collaborative Innovation Center of Hematology Peking University Beijing China

3. Peking‐Tsinghua Center for Life Sciences Beijing China

Funder

National Key Research and Development Program of China

Ministry of Science and Technology

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.34323

Reference46 articles.

1. Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis

2. THE CLINICAL SIGNIFICANCE OF MUTATIONS OF THE P52 TUMOUR SUPPRESSOR GENE IN HAEMATOLOGICAL MALIGNANCIES

3. Multifactorial analysis ofp53 alteration in human cancer: A review

4. p53 and Notch signaling in chronic lymphocytic leukemia: clues to identifying novel therapeutic strategies

5. p53, guardian of the genome